What this trial means for you
This study is active, not recruiting — it is not currently taking new participants, but its results may matter for treatments you're considering. It's studying Apraglutide for short bowel syndrome.
What participants typically get: study medication (or placebo, if the trial uses one) and study-related medical care at no cost, plus close monitoring. Compensation for time and travel varies by study — ask the site. Note that in many trials you can't choose your treatment group, and some participants receive a placebo.
The study, in the sponsor's words
The primary objective of the trial is to assess long-term safety and tolerability of apraglutide in subjects with SBS-IF.
Can you join? The exact criteria
Below is the verbatim eligibility text from the registry — bring it to your doctor; it's written for clinicians, and your own clinician is the right person to interpret it with you.
Full eligibility criteria (for you and your doctor)
Inclusion Criteria: 1. Males and females with a diagnosis of SBS-IF secondary to surgical resection of the small intestine, with Colon-in-Continuity (CIC) or stoma, who were trial subjects of parent trials TA799-007 or TA799-013 2. Able to give informed consent and agree to follow the details of participation as outlined in the protocol. Exclusion Criteria: 1. Subject not capable of understanding or not willing to adhere to the trial visit schedules and other protocol requirements. 2. Any other reason judged not eligible by the Investigator. 3. Pregnancy or lactation
Study sites by state
California
- Ronald Reagan UCLA Medical Center — Los Angeles
Florida
- Gastroenterology Group of Naples — Naples
Illinois
- Northwestern University - Chicago — Chicago
Michigan
- Henry Ford Health System — Detroit
Minnesota
- Mayo Clinic - Rochester — Rochester
Nebraska
- University of Nebraska Medical Center — Omaha
New York
- Mount Sinai Medical Center — New York
North Carolina
- Duke University Medical Center — Durham
Ohio
- Cincinnati Children's Hospital Medical Center — Cincinnati
- Cleveland Clinic Foundation — Cleveland
Pennsylvania
- Hospital of the University of Pennsylvania — Philadelphia
Tennessee
- Vanderbilt University Medical Center — Nashville
Washington
- University of Washington Medical Center — Seattle
View the official record on ClinicalTrials.gov →
Follow this trial
Get an email when our monthly digest covers enrollment changes and results for trials like this one.
Newsletter signup launches soon. (Site owner: set PUBLIC_BUTTONDOWN_USERNAME in
.env to activate this form.)